Mortality outcomes for COVID-19 patients in intensive care units
Citation: Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies. Anaesthesia. 2020 Jun 30.
What is this? Some patients with COVID-19 will become critically ill and need treatment in an intensive care unit (ICU).
In this rapid review, the authors searched for studies of ICU mortality for COVID-19 patients aged >18 years. They did not restrict their searches by language of publication and did the search on 31 May 2020. They included 24 studies (total: 10,150 patients) from Canada (1 study), China (8), Denmark (1), France (2), Hong Kong (1), Italy (1), the Netherlands (1), Singapore (1), Spain (1), UK (1) and USA (6).
What was found: At the time of this review, the meta-analysis of the included studies showed that the ICU mortality rate in COVID-19 patients with a completed ICU stay was 41.6%.
At the time of this review, the included studies showed that the reported ICU mortality rates fell above 50% in March 2020 to approximately 40% at the end of May 2020.
At the time of this review, the ICU mortality was broadly similar in different countries.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.